International Journal of Radiation Oncology*Biology*Physics

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
pp. 519-526(8)
Authors: Sneed P.K.; Suh J.H.; Goetsch S.J.; Sanghavi S.N.; Chappell R.; Buatti J.M.; Regine W.F.; Weltman E.; King V.J.; Breneman J.C.; Sperduto P.W.; Mehta M.P.

Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors
pp. 527-532(6)
Authors: Bhatnagar A.; Heron D.E.; Kondziolka D.; Lunsford L.D.; Flickinger J.C.

Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001
pp. 533-542(10)
Authors: Merchant T.E.; Kiehna E.N.; Sanford R.A.; Mulhern R.K.; Thompson S.J.; Wilson M.W.; Lustig R.H.; Kun L.E.

Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy
pp. 543-547(5)
Author: Paulino A.C.

Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04 ¹
pp. 548-557(10)
Authors: Komaki R.; Seiferheld W.; Ettinger D.; Lee J.S.; Movsas B.; Sause W.

Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer
pp. 558-565(8)
Authors: Liao Z.; Komaki R.; Stevens C.; Kelly J.; Fossella F.; Lee J.S.; Allen P.; Cox J.D.

Measurement of lung tumor volumes using three-dimensional computer planning software
pp. 566-573(8)
Authors: Bowden P.; Fisher R.; Mac Manus M.; Wirth A.; Duchesne G.; Millward M.; McKenzie A.; Andrews J.; Ball D.

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer
pp. 574-580(7)
Authors: Ritter M.A.; Gilchrist K.W.; Voytovich M.; Chappell R.J.; Verhoven B.M.

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer
pp. 581-587(7)
Authors: D'Amico A.V.; Keshaviah A.; Manola J.; Cote K.; Loffredo M.; Iskrzytzky O.; Renshaw A.A.

Risk group stratification in patients undergoing permanent ¹²⁵I prostate brachytherapy as monotherapy
pp. 588-594(7)
Authors: Kwok Y.; DiBiase S.J.; Amin P.P.; Naslund M.; Sklar G.; Jacobs S.C.

Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning
pp. 595-599(5)
Authors: Cellini N.; Morganti A.G.; Mattiucci G.C.; Valentini V.; Leone M.; Luzi S.; Manfredi R.; Dinapoli N.; Digesu' C.; Smaniotto D.

Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer
pp. 600-609(10)
Authors: Petrovich Z.; Lieskovsky G.; Langholz B.; Jozsef G.; Streeter O.E.; Skinner D.G.

Impact of postimplant edema on V₁₀₀ and D₉₀ in prostate brachytherapy: can implant quality be predicted on day 0?
pp. 610-621(12)
Authors: Waterman F.M.; Dicker A.P.

Saving bladders with brachytherapy: implantation technique and results
pp. 622-629(8)
Authors: Van der Steen-Banasik E.M.; Visser A.G.; Reinders J.G.; Heijbroek R.P.; Idema J.G.; Janssen T.G.; Leer J.W.

Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma
pp. 630-637(8)
Authors: Lee N.; Chuang C.; Quivey J.M.; Phillips T.L.; Akazawa P.; Verhey L.J.; Xia P.

Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma
pp. 638-647(10)
Authors: Hsiung C.-Y.; Yorke E.D.; Chui C.-S.; Hunt M.A.; Ling C.C.; Huang E.-Y.; Wang C.-J.; Chen H.-C.; Yeh S.-A.; Hsu H.-C.; Amols H.I.

Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy
pp. 648-655(8)
Authors: Prasad U.; Wahid M.I.A.; Jalaludin M.A.; Abdullah B.J.J.; Paramsothy M.; Abdul-Kareem S.

Trimodal combination therapy for maxillary sinus carcinoma
pp. 656-663(8)
Authors: Yoshimura R.-i.; Shibuya H.; Ogura I.; Miura M.; Amagasa T.; Enomoto S.; Kishimoto S.

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients
pp. 664-674(11)
Authors: Valentini V.; Coco C.; Picciocchi A.; Morganti A.G.; Trodella L.; Ciabattoni A.; Cellini F.; Barbaro B.; Cogliandolo S.; Nuzzo G.; Doglietto G.B.; Ambesi-Impiombato F.; Cosimelli M.

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies
pp. 675-679(5)
Authors: Vaishampayan U.N.; Ben-Josef E.; Philip P.A.; Vaitkevicius V.K.; Du W.; Levin K.J.; Shields A.F.

Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy
pp. 680-686(7)
Authors: DiBiase S.J.; Komarnicky L.T.; Heron D.E.; Schwartz G.F.; Mansfield C.M.

Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation
pp. 687-691(5)
Author: Deutsch M.

Extramedullary plasmacytoma: clinical and histopathologic study
pp. 692-701(10)
Authors: Strojan P.; Soba E.; Lamovec J.; Munda A.

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy
pp. 702-706(5)
Authors: Sood B.M.; Gorla G.; Gupta S.; Garg M.; Deore S.; Runowicz C.D.; Fields A.L.; Goldberg G.L.; Anderson P.S.; Vikram B.

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer
pp. 707-713(7)
Authors: Alektiar K.M.; McKee A.; Venkatraman E.; McKee B.; Zelefsky M.J.; Mychalczak B.R.; Hoskins W.J.; Barakat R.R.

Acute vasculitis after endovascular brachytherapy
pp. 714-719(6)
Authors: Fajardo L-G L.F.; Prionas S.D.; Kaluza G.L.; Raizner A.E.

Radiation oncologists in 2000: demographic, professional, and practice characteristics
pp. 720-728(9)
Authors: Cypel Y.; Sunshine J.H.; Schepps B.

The relationship between educational preparation and performance on the ARRT examination in radiation therapy
pp. 729-734(6)
Authors: Raymond M.R.; Washington C.M.

Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2'-deoxyguanosine, tumorigenesis, but not mortality, induced by -ray irradiation
pp. 735-743(9)
Authors: Inano H.; Onoda M.

Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge
pp. 744-756(13)
Authors: Zhao D.; Constantinescu A.; Hahn E.W.; Mason R.P.

MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans
pp. 757-765(9)
Authors: Mah D.; Steckner M.; Hanlon A.; Freedman G.; Milestone B.; Mitra R.; Shukla H.; Movsas B.; Horwitz E.; Vaisanen P.P.; Hanks G.E.

Improving the consistency in cervical esophageal target volume definition by special training
pp. 766-774(9)
Authors: Tai P.; Van Dyk J.; Battista J.; Yu E.; Stitt L.; Tonita J.; Agboola O.; Brierley J.; Dar R.; Leighton C.; Malone S.; Strang B.; Truong P.; Videtic G.; Wong C.S.; Wong R.; Youssef Y.

Comparison of methods for calculating rectal dose after ¹²⁵I prostate brachytherapy implants
pp. 775-785(11)
Authors: Hilts M.; Spadinger I.; Keyes M.

In regard to Mose et al., IJROBP 2001;51:1328-1335
pp. 786-786(1)
Author: Kunkler I.

In response to Dr. Kunkler
pp. 786-787(2)
Authors: Mose S.; Budischweski K.M.

In regard to the radiotherapy of myxopapillary ependymomas
pp. 787-787(1)
Authors: Peter Rutz H.; Goitein G.